 |
|
 |
| biography | articles | blog | media coverage | spoken | audio/video | announcements | mailing list |
Latest Articles
Cuomo's Out of Control Craving for an Opioid Slush Fund
March 21, 2019 • RealClear Policy
Sometimes a bad idea is a bad idea, no matter how you package it. New York Governor Andrew Cuomo is trying again, after his $600 million opioid tax was slapped down in December by an Obama appointed federal judge.
Proponents of the earlier tax scheme pointed to a key provision which forbade manufacturers from passing along the cost to patients. This was an essential element of the plan — who in their right mind would want to punish patients whose doctors legitimately prescribe opioids for acute pain?
Even supporters of sin-taxes recognize the folly of squeezing vulnerable patients to pay for an opioid crisis now fueled by the illegal fentanyl trade.
Continue to the full article | More articles
Smokeless Tobacco Can Save Lives, But Only if Smokers Have All the Facts
February 1, 2019 • Real Clear Policy
When products have the potential to save millions of lives, it's helpful if people are told about those benefits. The Food and Drug Administration (FDA) can do just that as it considers allowing manufacturers of non-combustible tobacco products to notify smokers that completely switching from cigarettes to smokeless tobacco products can save lives.
Continue to the full article | More articles
A Patently Reasonable Approach to Addressing Pharmaceutical Prices
January 15, 2019 • Morning Consult
We seem to be at an impasse when it comes to getting the prices of prescription drugs under control for patients while at the same time fostering innovation. This need not be the case.
Continue to the full article | More articles
Both Parties Can Work Together to Lower Drug Prices
November 27, 2018 • Washington Examiner
Healthcare was a key issue for voters in the split-decision midterm elections. So are we in for more partisan divide and no progress? Not necessarily. We simply need to reframe the debate to find common ground.
The Democrat-controlled House won't consider Obamacare repeal, and the Republican Senate won't consider Medicare for all. But there are ways to make constructive changes without relying on ideologically charged policies which can't advance in this environment.
Continue to the full article | More articles
What is Scott Gottlieb Smoking
November 18, 2018 • Daily Caller
The FDA's just-unveiled Draconian restrictions on vaping products are an example of good PR but bad public-health policy. And regulators know better.When he headed the FDA, Dr. Frank Young used to admonish his minions that there were times when common sense should modulate established policies and rules. That can be done in federal agencies via "enforcement discretion," a tool that regulators use to carry out their mandate in light of sometimes ambiguous laws and regulations.Other officials have not been so wise.Take Young's successor at the FDA, David Kessler, who chose a ludicrous case calculated to get him on the evening news in a virile demonstration that he was tough at enforcing the law.Most Viewed
home | biography | articles | blog | media coverage | spoken | audio/video | announcements | mailing list | mobile site